Integrated CBD closed a $50 million funding round on Tuesday, raising a mix of equity and debt from investors. The bulk of the debt, $30 million, was provided by an undisclosed $7.5 billion hedge fund.
Unlike its high-inducing cousin, THC, CBD, or cannabidiol, is federally legal in the US. That means that institutional investors are able to lend to CBD-only facilities, lowering the cost of capital for operators.
And it could become a huge market. Analysts at the investment bank Cowen expect CBD to become a $16 billion market in the US alone by 2025.
Integrated CBD's CEO, Patrick Horsman, told Business Insider in a Tuesday interview that manufacturing CBD at an industrial scale takes a lot of capital to get off the ground. He didn't want to put his company at a disadvantage by paying high-interest rates or diluting too much of his and his cofounders' equity in the company.
According to the specifics of the deal, Integrated CBD is giving up a small number of warrants to the debt investor and paying back the money with an interest rate in the low teens.
"So that's pretty attractive given some of the financing options we're seeing in the cannabis industry," Horsman said. Because of the history of cannabis — and the murky conflict between state and federal law in the US — cannabis and hemp companies often pay upwards of 20% when they take on debt.
"It had been a really good fundraising environment until June," Horsman said. But since public cannabis stocks saw their share prices plummet over the summer, the private markets have tightened up accordingly.
"Some of the banks have egg on their face from deals this summer," Horsman said. "The spigot hasn't completely turned off but investors are being a lot more careful writing checks."
In any case, Integrated CBD has been on fundraising tear this year. Since January, Horsman said the company raised a $3.3 million pre-seed round from friends and family. In March, the CBD manufacturer closed a $10 million seed round, and then brought in another $15 million through an equipment lease facility that was used to help build out their main hemp-oil producing facility in Arizona.
Read more: A California company tested 20 popular CBD products and found 'insanely high levels' of dangerous chemicals and misleading labels
Horsman said the company closed on the debt facility in late August, and then brought in another $20 million from equity investors over the past few weeks as part of the Series A round. The equity investors, Horsman said, are mostly a mix of family offices, hedge funds, and some hedge fund managers Horsman had in his network who ended up investing their personal money into Integrated CBD.
Navy Capital, a cannabis-focused hedge fund in New York, also participated in an earlier financing round. "Capital drying up in cannabis has made it a great time to deploy to differentiated stories where valuations are at reasonable levels with the thesis still fully intact," Sean Stiefel, Navy Capital's CEO, said in an email.
Horsman said the company has already engaged bankers to raise a Series B, though he declined to disclose the name of the bank. His goal is to raise $100 million this year, in order to build out the company's 10,000-acre hemp farm in Arizona — they planted their first organic-certified crop in June. It's also building an extraction and manufacturing facility to produce the CBD oil at an industrial scale near Phoenix
The facility is set to launch in the first quarter of next year, and Horsman said he is hiring engineers and managers from a recently decommissioned Honeywell plant in the area to staff the facility.
Besides the capital projects, Integrated CBD is building out its sales, engineering, and accounting and finance teams, Horsman said.
Because of what Horsman says is "widespread fraud" in the organic space, Integrated CBD has also partnered with Verified Organic, a blockchain-based system for ensuring the entire seed-to-sale supply chain of CBD oil is, in fact, certified organic.
Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Value-Based Care Model: Pay-for-Performance Healthcare - Senior Care & Assisted Living Market Trends - Smart Medical Devices: Wearable Tech in Healthcare - AI in Healthcare - Remote Patient Monitoring Industry: Devices & Market Trends
Cbd Isolate, Cbd Oil, Cbd Wax, Cannabidiol Isolate, Cbd Extract - Hongbao,http://www.yuxihongbao.com/